Frontiers in Cardiovascular Medicine (Dec 2023)

In-hospital and 1-year outcomes of patients without modifiable risk factors presenting with acute coronary syndrome undergoing PCI: a Sex-stratified analysis

  • Ali Sheikhy,
  • Ali Sheikhy,
  • Aida Fallahzadeh,
  • Aida Fallahzadeh,
  • Mana Jameie,
  • Mana Jameie,
  • Afsaneh Aein,
  • Afsaneh Aein,
  • Farzad Masoudkabir,
  • Farzad Masoudkabir,
  • Milad Maghsoudi,
  • Masih Tajdini,
  • Masih Tajdini,
  • Mojtaba Salarifar,
  • Mojtaba Salarifar,
  • Yaser Jenab,
  • Yaser Jenab,
  • Hamidreza Pourhosseini,
  • Hamidreza Pourhosseini,
  • Mehdi Mehrani,
  • Mehdi Mehrani,
  • Mohammad Alidoosti,
  • Mohammad Alidoosti,
  • Ali Vasheghani-Farahani,
  • Kaveh Hosseini,
  • Kaveh Hosseini

DOI
https://doi.org/10.3389/fcvm.2023.1235667
Journal volume & issue
Vol. 10

Abstract

Read online

AimA considerable proportion of patients admitted with acute coronary syndrome (ACS) have no standard modifiable cardiovascular risk factors (SMuRFs: hypertension, diabetes mellitus, dyslipidemia, and cigarette smoking). The outcomes of this population following percutaneous coronary intervention (PCI) are debated. Further, sex differences within this population have yet to be established.MethodsThis retrospective cohort study included 7,847 patients with ACS who underwent PCI. The study outcomes were in-hospital mortality, all-cause mortality, and major adverse cardio-cerebrovascular events (MACCE). The association between the absence of SMuRFs (SMuRF-less status) and outcomes among all the patients and each sex was assessed using logistic and Cox proportional hazard regressions.ResultsApproximately 11% of the study population had none of the SMuRFs. During 12.13 [11.99–12.36] months of follow-up, in-hospital mortality (adjusted-odds ratio (OR):1.51, 95%confidence interval (CI): 0.91–2.65, P:0.108), all-cause mortality [adjusted-hazard ratio (HR): 1.01, 95%CI: 0.88–1.46, P: 0.731], and MACCE (adjusted-HR: 0.93, 95%CI:0.81–1.12, P: 0.412) did not differ between patients with and without SMuRFs. Sex-stratified analyses recapitulated similar outcomes between SMuRF+ and SMuRF-less men. In contrast, SMuRF-less women had significantly higher in-hospital (adjusted-OR: 3.28, 95%CI: 1.92–6.21, P < 0.001) and all-cause mortality (adjusted-HR:1.41, 95%CI: 1.02–3.21, P: 0.008) than SMuRF+ women.ConclusionsAlmost one in 10 patients with ACS who underwent PCI had no SMuRFs. The absence of SMuRFs did not confer any benefit in terms of in-hospital mortality, one-year mortality, and MACCE. Even worse, SMuRF-less women paradoxically had an excessive risk of in-hospital and one-year mortality.

Keywords